SteinCares
  • Home
  • Company
    • Who We are
    • Our Milestones
    • Our Presence
  • Business Segments
    • Innovative
    • Biosimilars
    • Complex Generics
    • Therapeutic Areas
  • Partnerships
    • Pillars of Successful Partnerships
    • Our Partnership Solutions
  • Press Releases
  • Contact us
  • ESP
Select Page
SteinCares Earns AA Rating from Moody’s, Reflecting Strong Financial Profile, Operational Excellence, and Robust Governance

SteinCares Earns AA Rating from Moody’s, Reflecting Strong Financial Profile, Operational Excellence, and Robust Governance

by victoria.carrillo | Jan 19, 2026 | Press Releases

San Jose, Costa Rica, January 19th, 2026 — SteinCares announced today that Moody’s Investors Service has assigned the company an AA credit rating with Stable outlook, highlighting its solid financial position, resilient business model, and disciplined operational...

Recent Posts

  • SteinCares Strengthens its Onco-Hematology Portfolio with the Introduction of Spectrila® in Brazil
  • SteinCares and Shilpa Biologicals Strike into licensing agreement to Expand Access to Biosimilars Across Latin America
  • SteinCares Earns AA Rating from Moody’s, Reflecting Strong Financial Profile, Operational Excellence, and Robust Governance
  • SteinCares Expands its Portfolio in Brazil with Monofer®
  • SteinCares Opens New Facility in Costa Rica to Strengthen Access to Specialty Healthcare Across Latin America

Recent Comments

No comments to show.